Investment is a Waiting Game: Mini Update from Managing Director
Dear Reader,
We’d like to apologise for our absence and inconsistency in our posting activities. We had planned for 2023 to be the year to springboard growth for the company. However, by August 2023 our plans were derailed by unapproved amendments to an investment deal, unforeseen operational changes by appointed service partner and the negligent damage to our current stock. Due this catalogues of disruptions, it resulted in the business having to concentrate its efforts on stabilizing and navigating through this thorny period. Sadly the decisive actions we took have impacted our agility and growth for 2023 heading into early 2024. It would be no stretch of the English language to deem 2023 as an annus horribilis for Nnadi’s Healthcare & Pharmaceuticals.
Despite the hurdles of learning and operational obstacles to surmount, we persevere not out of foolishness or folly but out of a sense of duty and determination to contribute something positive to the country. Something positive for the nation’s economy and the health of the population too. Through Fergie’s Sparkling Water®, we have had the opportunity to connect and listen to people. We have come to gain an insight into people’s relationship with their nutrition, GP and the NHS as a whole. Through these conversations with the public, it is apparent there is still much work to do. Aside from these conversations, I would be remiss not to mention and acknowledge the kind words of support and gradual return business we have accrued in spite of all these difficulties since August 2023. We are grateful to these customers and supporters, we shall repay their faith by continuing to make strides towards securing investment.
Our path towards securing investment now adopts a strategy of patience (as much as we can afford). The investment climate in the UK is constricted and conservative to nascent SME science ventures. According to an experienced business advisor, investments in the UK have dropped by 61%. Aside from the slow velocity of investment capital, there seems to be a shortage of courage and patience towards modest & sustainable business model. Investing in STEM ventures is not for the faint-hearted, but it is an investment that pays dividends both financially and socially. In this climate, we have to wait discerningly for the correct investing partner that will pull us out of the vicious cycle of traction against capital. I have full confidence in the company’s potential and mission. I hope this is a sentiment shared by our investors. We shall indeed wait and see.
In the meantime, we shall continue with our daily operational activities and ambitions.
We have come to accept that investment is very much now a waiting game.
Kindest Regards,
Sonny Ume
Founder & Managing Director









